ArticleTranslational cancer research2019

Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer.

Feng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.